Fibrosis linked with mortality, liver-related morbidity risk in patients with NAFLD

Biopsy-confirmed fibrosis was associated with risk for mortality and liver-related morbidity in patients with NAFLD, regardless of confounding factors and in patients with NASH, according to study results.
Rod S. Taylor, MSc, PHD, chair of population health research at the University of Glasgow, and colleagues wrote that it is widely accepted that liver fibrosis develops as a result of liver injury secondary to steatohepatitis in patients with NAFLD.
“Given that disease activity in NASH may fluctuate over time and liver biopsy may be subject to sampling variability, some patients with

Source link

Related posts

Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium


Elsewhere in The AGA Journals (Preview Section)


Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy